Biomarkers Transform R&D
FDA defines a biomarker as a characteristic “objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to...
Trends in Mass Spec: Understanding a Drug’s Metabolic Profile
The annual meeting of the American Association of Mass Spectrometry held in June featured the debut of many improved and modified mass spec instruments...
David Weiner, Ph.D.
from the University of Pennsylvania School of Medicine and Editor of DNA and Cell Biology - a peer-review journal published by Mary Ann Liebert, Inc. - talks with GEN's Editor-in-Chief John Sterling about DNA vaccines.
Dr. Una Ryan
- from Avant Immunotherapeutics, talks with GEN's Editor-in-Chief John Sterling about recent developments in vaccine research.
Assay Tutorial: Adenoviral Vector Gene Delivery System
Biological assays in established and primary cells can greatly aid the drug discovery process. Stable cell (inheritable genotype) lines are chosen for their consistent...
